Advertisement

Advertisement

CARL Stock Latest News

Carlsmed initiated with a Buy at Needham

The FlyCarlsmed initiated with a Buy at Needham

Carlsmed Shareholders Back Directors and Auditor at Meeting

PremiumCompany Announcements

Carlsmed Shareholders Back Directors and Auditor at Meeting

2M ago

Zimmerman Reiterates Buy on Carlsmed After Strong Q1, Raises 2026 Outlook and Keeps $23 Price Target Unchanged

PremiumRatings

Zimmerman Reiterates Buy on Carlsmed After Strong Q1, Raises 2026 Outlook and Keeps $23 Price Target Unchanged

3M ago

Carlsmed Earnings Call Highlights Growth, Rising Costs

PremiumCompany Announcements

Carlsmed Earnings Call Highlights Growth, Rising Costs

3M ago

Carlsmed reports Q1 EPS (32c), consensus (40c)

PremiumThe Fly

Carlsmed reports Q1 EPS (32c), consensus (40c)

3M ago

Carlsmed raises FY26 revenue view to $72M-$77M from $70M-$75M

PremiumThe FlyCarlsmed raises FY26 revenue view to $72M-$77M from $70M-$75M

3M ago

Carlsmed price target lowered to $18 from $20 at Truist

The Fly

Carlsmed price target lowered to $18 from $20 at Truist

4M ago

Carlsmed price target lowered to $23 from $24 at BTIG

The Fly

Carlsmed price target lowered to $23 from $24 at BTIG

4M ago

Carlsmed Earnings Call Highlights Rapid Growth, Rising Costs

PremiumCompany Announcements

Carlsmed Earnings Call Highlights Rapid Growth, Rising Costs

5M ago

Carlsmed announces first procedure with corra Cervical Plating System

PremiumThe Fly

Carlsmed announces first procedure with corra Cervical Plating System

6M ago

Carlsmed announces completion of first posterior lumbar spine surgery

PremiumThe Fly

Carlsmed announces completion of first posterior lumbar spine surgery

6M ago

Carlsmed sees Q4 revenue $15.2M, up 61% year-over-year

PremiumThe Fly

Carlsmed sees Q4 revenue $15.2M, up 61% year-over-year

7M ago

Carlsmed price target raised to $20 from $19 at Goldman Sachs

PremiumThe FlyCarlsmed price target raised to $20 from $19 at Goldman Sachs

7M ago

Carlsmed publishes new retrospective cohort study in Global Spine

The Fly

Carlsmed publishes new retrospective cohort study in Global Spine

7M ago

Carlsmed announces U.S. launch of its aprevo Technology Platform

The Fly

Carlsmed announces U.S. launch of its aprevo Technology Platform

8M ago

Carlsmed price target raised to $24 from $21 at BTIG

PremiumThe Fly

Carlsmed price target raised to $24 from $21 at BTIG

9M ago

Carlsmed Reports Strong Q3 Growth and Raises Guidance

PremiumCompany Announcements

Carlsmed Reports Strong Q3 Growth and Raises Guidance

9M ago

Carlsmed raises FY25 revenue view to $49M-$50M from $45.5M-$47.5M

PremiumThe Fly

Carlsmed raises FY25 revenue view to $49M-$50M from $45.5M-$47.5M

9M ago

Carlsmed reports Q3 EPS (40c), consensus (49c)

PremiumThe Fly

Carlsmed reports Q3 EPS (40c), consensus (49c)

9M ago

Carlsmed Secures $60 Million Credit Facility Amendment

PremiumCompany AnnouncementsCarlsmed Secures $60 Million Credit Facility Amendment

9M ago

Carlsmed appoints Jennifer Kamocsay as CLO, secretary

The Fly

Carlsmed appoints Jennifer Kamocsay as CLO, secretary

10M ago

Carlsmed announces inclusion in Russell 2000 Index

The Fly

Carlsmed announces inclusion in Russell 2000 Index

10M ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >